Kenvue Inc. (NYSE:KVUE) Receives $21.18 Average PT from Analysts

Kenvue Inc. (NYSE:KVUE) has been assigned a consensus recommendation of “Hold” from the sixteen research firms that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, nine have issued a hold recommendation, five have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month price target among brokerages that have covered the stock in the last year is $21.1786.

Several brokerages have commented on KVUE. Rothschild & Co Redburn upgraded Kenvue from a “neutral” rating to a “buy” rating and cut their target price for the stock from $22.50 to $22.00 in a research note on Friday, September 26th. Barclays cut their target price on Kenvue from $20.00 to $17.00 and set an “equal weight” rating for the company in a research note on Wednesday, October 1st. JPMorgan Chase & Co. cut their target price on Kenvue from $24.00 to $21.00 and set an “overweight” rating for the company in a research note on Friday, October 10th. The Goldman Sachs Group cut their target price on Kenvue from $22.00 to $19.00 and set a “neutral” rating for the company in a research note on Thursday, October 2nd. Finally, Rothschild Redb upgraded Kenvue from a “hold” rating to a “strong-buy” rating in a research note on Friday, September 26th.

Institutional Trading of Kenvue

Several institutional investors and hedge funds have recently modified their holdings of the business. Capital Investment Advisors LLC raised its holdings in shares of Kenvue by 14.5% in the 3rd quarter. Capital Investment Advisors LLC now owns 13,701 shares of the company’s stock valued at $222,000 after acquiring an additional 1,733 shares in the last quarter. Sound Financial Strategies Group LLC raised its holdings in shares of Kenvue by 3.2% in the 3rd quarter. Sound Financial Strategies Group LLC now owns 33,936 shares of the company’s stock valued at $551,000 after acquiring an additional 1,068 shares in the last quarter. Invested Advisors purchased a new stake in shares of Kenvue in the 3rd quarter valued at about $238,000. Kingswood Wealth Advisors LLC raised its holdings in shares of Kenvue by 13.5% in the 3rd quarter. Kingswood Wealth Advisors LLC now owns 18,851 shares of the company’s stock valued at $306,000 after acquiring an additional 2,246 shares in the last quarter. Finally, Kennon Green & Company LLC raised its holdings in shares of Kenvue by 4.4% in the 3rd quarter. Kennon Green & Company LLC now owns 221,949 shares of the company’s stock valued at $3,602,000 after acquiring an additional 9,305 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Kenvue Stock Down 0.8%

KVUE stock opened at $15.07 on Tuesday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.98. The company has a market capitalization of $28.91 billion, a price-to-earnings ratio of 20.36, a PEG ratio of 2.19 and a beta of 0.72. Kenvue has a fifty-two week low of $14.05 and a fifty-two week high of $25.17. The stock has a fifty day moving average of $18.03 and a 200-day moving average of $20.84.

Kenvue (NYSE:KVUE) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.29 earnings per share for the quarter, topping the consensus estimate of $0.28 by $0.01. The company had revenue of $3.84 billion during the quarter, compared to the consensus estimate of $3.94 billion. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.The firm’s quarterly revenue was down 4.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.32 EPS. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, equities research analysts predict that Kenvue will post 1.14 earnings per share for the current year.

Kenvue Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, August 27th. Shareholders of record on Wednesday, August 13th were issued a $0.2075 dividend. This represents a $0.83 annualized dividend and a dividend yield of 5.5%. The ex-dividend date of this dividend was Wednesday, August 13th. This is an increase from Kenvue’s previous quarterly dividend of $0.21. Kenvue’s payout ratio is 112.16%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.